W. R. Grace & Co.-Conn. Q4 FY2026 earnings call

• Strategic Position & Technology: NanoExplore is positioned as the global leader in commercial-scale graphene with up to 5,000 tons of annual capacity. The company successfully transitioned its proprietary D-series graphene technology from development to commercial production, enabling new high-margin applications.
• Leadership & Safety: Completed CEO leadership transition; promoted Nima Moghimian to CTO and Ilia Chliapnikov to COO. Achieved best-in-company-history safety record, reducing total recordable injury frequency from 9.99 to 3.10.
• Platform Strategy: Differentiates between X-series (high aspect ratio) and newly launched D-series (high surface area) graphene. D-series enables higher loading levels in applications like cement and foams, driving better margins compared to traditional low-loading finished goods.
• Tribograph (Drilling Fluids): Multi-year supply agreement with CP Chem for 'NanoSlide' remains valid. While rollout is slower than initially expected due to a prospective customer loss on the buyer's side, lab validation continues across all customers. Management maintains high conviction in the product's cost advantage and performance.
• Insulating Foams: Active development with major producers covering ~80% of North American market share. One key customer expects to convert to graphene master batch immediately, targeting 1,000 tons in the first full year of production. Signed LOI with a leading global PU foam producer to address regulatory phase-outs of halogenated flame retardants.
• Plastic Films: Technical innovation with Tecmo PM shows >70% improvement in mechanical strength and potential for 20% thickness reduction. Targeting start of order flow in H2 FY2027. Low loading (<1%) but significantly higher selling price per kilogram.
• Conductive Graphene: Launched XGMP D500HP for energy storage and electronics. Currently selling to an Asian customer; expanding pipeline.
• Recycled Plastics: Working with ClubGuard to convert products to graphene-enhanced recycled polymers, expected early 2027.
• Volta Explore: Repositioned from EV focus to defense/dual-use (UAVs/UGVs). Operating 1 MWh facility in Montreal. Supplying cells for testing/qualification; supported by federal grants.

The Advanced Materials, Plastics, and Composite product segment generated an Adjusted EBITDA of $2 million in Q4 2026, a decrease of $650,000 year-over-year primarily due to lower tooling revenues. The Battery Cells and Materials segment reported an Adjusted EBITDA loss of $140,000, representing an improvement of $80,000 compared to the prior year. For the full fiscal year 2026, total sales were $117.3 million (down from $129 million in FY2025), driven by normalized tooling revenues and volume recovery in PACCAR and Volvo programs. Full-year Adjusted EBITDA was $1.93 million (down from $6.1 million in FY2025). Excluding tooling revenues, Q4 revenue grew 17% year-over-year, and full-year results reflect strong performance in the latter three quarters.

• FY2027 Revenue: Guidance increased/maintained at $130–$140 million, representing 11–20% growth year-over-year. This range excludes delayed Volvo programs (pushed to FY2028).
• FY2027 Free Cash Flow: Management expects to deliver positive free cash flow, citing record highs if targets are met.
• FY2028 Revenue: Internal expectations indicate revenue between $160–$170 million, driven by the ramp-up of previously delayed Volvo programs and continued graphene commercialization.
• Q1 FY2027 Revenue: Expected between $30.5–$31 million (up 32% YoY).
• CAPEX: Expected to reduce significantly beginning Q1 2027, running at less than $1 million per quarter, barring new strategic capacity expansions.

• Commercial Rollout Pace: Tribograph adoption timeline is longer than expected due to industry sales cycles and specific customer-side commercial issues, not product performance.
• Margin Dilution: Current mix includes lower-margin finished goods where graphene loading is <5%. Margin expansion depends on scaling higher-loading graphene applications.
• Raw Material Costs: US-Iran conflict caused raw material price increases, partially mitigated by customer price hikes with a lag effect.
• Regulatory/Delay Risks: Two new Volvo programs delayed to FY2028 due to industry regulatory changes associated with the Trump administration.
• Working Capital: Elevated working capital due to unbilled tooling receivables ($8 million impact), expected to normalize in FY2027.
• Capacity Constraints: D-series capacity may require expansion (~$2M investment) sooner than X-series if demand accelerates.

Q: James McGargo (RBC Capital Markets) asked about the drivers behind the FY2027 revenue guidance of $130-140 million and whether graphene initiatives could provide upside beyond this range. / A: CFO Pedro Azevedo explained that the guidance relies on the full-year contribution of the ClubCar business and volume recovery in PACCAR/Volvo programs. He noted that while graphene sales will significantly boost margins, their direct revenue contribution is incremental (e.g., 500 tons = ~$5M) and unlikely to drive massive top-line jumps alone. The FY2028 outlook of $160-170 million is more confident because it includes the now-delayed Volvo programs starting in that year.

Q: Betu Sidhu (National Bank of Canada) inquired if the delay in Tribograph/NanoSlide commercialization posed a systemic risk or if the lost customer opportunity was an isolated incident. / A: CEO Rocco Marinaccio characterized the lost customer as a 'one-off' learning curve event related to commercial issues on the buyer's side, not product failure. He emphasized that every customer who has completed lab testing has validated the product's performance. The delay is attributed to the natural, slow sales cycle of converting lab results to field trials, but management retains high conviction in the long-term value proposition.

Q: Michael Glenn (Raymond James) asked if current graphene capacity is sufficient to support the FY2028 revenue target of $160-170 million without additional capital expenditure. / A: Azevedo stated that current capacity meets immediate visible needs for FY2027. However, hitting FY2028 targets likely requires D-series capacity expansion, which would cost ~$2 million. He noted that D-series profitability should fund its own expansion. Capacity utilization varies heavily by product grade (e.g., high-purity grades yield lower tonnage), so revenue potential depends on the mix of products sold rather than just total tonnage.

Q: Marvin Wolf (Paradigm Capital) asked for technical clarification on why D-series graphene succeeds in cement applications where X-series failed commercially. / A: Marinaccio clarified that X-series performed well in lab compression tests but failed to maintain consistency during commercial field application. D-series offers consistent dispersion and behavior in real-world environments. Additionally, NanoExplore’s status as the lowest-cost commercial producer provides a critical cost advantage necessary for penetrating the bulk cement market.